Tong Ren Tang Technologies Co. Ltd. (HKG:1666)
Hong Kong · Delayed Price · Currency is HKD 3.050
+0.070 (2.35%)
Oct 26, 2026, 4:08 PM HKT
HKG:1666 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 5,770 | 6,484 | 7,260 | 6,773 | 5,992 | 5,400 |
Revenue Growth | -11.01% | -10.69% | 7.18% | 13.05% | 10.95% | 17.21% |
Gross Profit Gross Profit Growth | 2,128 | 2,466 | 2,877 | 2,848 | 2,592 | 2,291 |
Operating Income Operating Income Growth | 661.36 | 802.14 | 985.16 | 1,116 | 1,213 | 1,080 |
Net Income Net Income Growth | 306.75 | 396.28 | 521.8 | 590.19 | 582.89 | 507.25 |
Earnings Per Share EPS Growth | 0.24 | 0.31 | 0.41 | 0.46 | 0.46 | 0.40 |
EPS Growth | -22.59% | -24.05% | -11.59% | 1.25% | 14.91% | 8.49% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Others Others Growth | 1,570 | 1,962 | 2,244 | 2,390 | 1,904 | 1,385 |
Tong Ren Tang Chinese Medicine Tong Ren Tang Chinese Medicine Growth | 1,216 | 1,388 | 1,473 | 1,377 | 1,495 | 1,292 |
The Company The Company Growth | 3,764 | 4,025 | 4,458 | 4,074 | 3,492 | 3,286 |
Inter-Segment Inter-Segment Growth | -780.2 | -891.22 | -915.64 | -1,067 | -899.57 | -562.2 |
Total Total Growth | 5,770 | 6,484 | 7,260 | 6,773 | 5,992 | 5,400 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,005 | 4,834 | 4,381 | 4,238 | 4,183 | 3,888 |
Total Debt Total Debt Growth | 1,911 | 2,004 | 2,425 | 1,627 | 1,595 | 1,644 |
Net Cash (Debt) Net Cash Growth | 3,094 | 2,829 | 1,956 | 2,611 | 2,588 | 2,244 |
Net Cash Growth | 9.35% | 44.64% | -25.08% | 0.89% | 15.31% | 24.81% |
Net Cash Per Share Net Cash Per Share Growth | 2.42 | 2.21 | 1.53 | 2.04 | 2.02 | 1.75 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,208 | 1,562 | 15.61 | 554.18 | 723.77 | 1,033 |
Capital Expenditures CapEx Growth | -93.05 | -116.82 | -174.16 | -103.39 | -157.92 | -156.41 |
Free Cash Flow Free Cash Flow Growth | 1,115 | 1,446 | -158.56 | 450.78 | 565.85 | 877.01 |
Free Cash Flow Growth | -22.87% | - | - | -20.34% | -35.48% | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 36.88% | 38.02% | 39.64% | 42.04% | 43.26% | 42.43% |
Operating Margin | 11.46% | 12.37% | 13.57% | 16.48% | 20.25% | 19.99% |
Pretax Margin | 11.52% | 12.68% | 14.62% | 17.16% | 20.23% | 19.35% |
Profit Margin | 5.32% | 6.11% | 7.19% | 8.71% | 9.73% | 9.39% |
FCF Margin | 19.32% | 22.30% | -2.18% | 6.65% | 9.44% | 16.24% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.210 | 0.180 | 0.180 | 0.180 | 0.160 | 0.160 |
Dividend Per Share Growth | 5.26% | 0% | 0% | 12.50% | 0% | 0% |
Dividend Yield | 6.89% | 4.54% | 3.69% | 3.03% | 3.20% | 2.34% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.03 | 12.81 | 11.97 | 12.90 | 10.98 | 17.24 |
Forward PE | 7.24 | 9.16 | 8.91 | 11.24 | 10.63 | 15.88 |
P/FCF Ratio | 2.97 | 3.51 | - | 16.89 | 11.31 | 9.97 |
PS Ratio | 0.57 | 0.78 | 0.86 | 1.12 | 1.07 | 1.62 |